Status:
UNKNOWN
WGS-guided Tracking and Infection Control Measures of CRKP
Lead Sponsor:
Huashan Hospital
Collaborating Sponsors:
Sumitomo Pharmaceuticals (Suzhou) Co. Ltd
Conditions:
Klebsiella Pneumoniae Infection
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The objective of this study is to investigate the effect of the infection control measures based on the active screening of carbapenem-resistant Klebsiella pneumoniae and whole-genome based tracking a...
Eligibility Criteria
Inclusion
- The patient was admitted to the ICU of neurosurgery in the west hospital of huashan hospital affiliated to fudan university from September 2019 to September 2021, or transferred from the ICU of another hospital
- The patient is more than 18 years old and less than 80 years old, regardless of gender.
- Informed consent of the patient;
Exclusion
- Patients participating in other clinical trials at the same time
- Pregnant
- 4\. People who will affect the outcome of the study: whose specimens could not be received or not enough for testing
Key Trial Info
Start Date :
May 28 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2021
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04413305
Start Date
May 28 2020
End Date
September 30 2021
Last Update
June 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Infectious department of Huashan Hospital, Fudan University
Shanghai, China, 200040